Fitch Ratings has affirmed Quest Diagnostics, Inc. s Long-Term Issuer Default Rating , senior unsecured revolving facility and senior unsecured notes at BBB .
The Rating Outlook remains.
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2023 Earnings Call Transcript February 1, 2024 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.15, expectations were $2.14. Quest Diagnostics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Quest Diagnostics Fourth […]
Quest Diagnostics Incorporated (NYSE:DGX) Q3 2023 Earnings Call Transcript October 24, 2023 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is $2.22, expectations were $2.19. Operator: Welcome to the Quest Diagnostics Third Quarter 2023 Conference Call. At the request of the company, this call is being recorded. The entire contents of the call, including the […]